High insulin levels are associated with increased breast cancer risk and poor patient survival outcome [17, 48]; therefore, metformin directly and indirectly reduces cancer cell proliferation through reduction of insulin levels and blood glucose levels. The gene discussed is INS; the disease is cancer.